Functional mapping of androgen receptor enhancer activity
C.-C. F. Huang, S. Lingadahalli, T. Morova, D. Ozturan, E. Hu, I. P. L. Yu, S. Linder, M. Hoogstraat, S. Stelloo, F. Sar, H. van der Poel, U. B. Altintas, M. Saffarzadeh, S. Le Bihan, B. McConeghy, B. Gokbayrak, F. Y. Feng, M. E. Gleave, A. M. Bergman, C. Collins, F. Hach, W. Zwart, E. Emberly, N. A. Lack
Abstract
Androgen receptor (AR) is critical to the initiation, growth and progression of almost all prostate cancers. Once activated, the AR binds to cis-regulatory enhancer elements on DNA that drive gene expression. Yet, there are 10-100x more binding sites than differentially expressed genes. It still remains unclear how individual sites contribute to AR-mediated transcription. While descriptive functional genomic approaches broadly correlate with enhancer activity, they do not provide the locus-specific resolution needed to delineate the underlying regulatory logic of AR-mediated transcription. Therefore, we functionally tested all commonly occuring clinical AR binding sites with Self-Transcribing Active Regulatory Regions sequencing (STARRseq) to generate the first map of intrinsic AR enhancer activity. This approach is not significantly affected by endogenous chromatin modifications and measures the potential enhancer activity at each cis-regulatory element. Interestingly we found that only 7% of AR binding sites displayed increased enhancer activity upon hormonal stimulation. Instead, the vast majority of AR binding sites were either inactive (81%) or constitutively active enhancers (11%). These annotations strongly correlated with enhancer-associated features in both cell line and clinical prostate cancer. With these validated annotations we next investigated the effect of each enhancer class on transcription and found that AR-driven inducible enhancers frequently interacted with promoters, forming central chromosomal loops critical for gene transcription. We demonstrated that these inducible enhancers act as regulatory hubs that increase contacts with both other AR binding sites and gene promoters. This functional map was used to identify a somatic mutation that significantly reduces the expression of a commonly mutated AR-regulated tumour suppressor. Together, our data reveal a complex interplay between different AR binding sites that work in a highly coordinated manner to drive gene transcription.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Motif-based model of transcription predicts effects of sequence variants in AR enhancers and reveals distinct functions for AR-associated transcription factors
Hoda Taeb, Amin Safaeesirat, … Eldon G. Emberly·bioRxiv·Sep 7, 2026
- Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription
Umut Berkay Altıntaş, Ji-Heui Seo, … Nathan A. Lack·Nature CommunicationsPeer-reviewed·Nov 3, 2024
- Androgen receptor binding sites are highly mutated in prostate cancer
T. MOROVA, M. GÖNEN, … N. A. LACK·Oncology AbstractsPeer-reviewed·Sep 26, 2019
- Dynamic phase separation of the androgen receptor and its coactivators to regulate gene expression.
F. Zhang, S. Wong, … N. Lallous·bioRxiv·Mar 27, 2021
- Canonical AREs are tumor suppressive regulatory elements in the prostate
Xuanrong Chen, Michael A. Augello, … Christopher E. Barbieri·Nature CommunicationsPeer-reviewed·Dec 13, 2024
- NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Abhijit Parolia, Sanjana Eyunni, … Irfan Ahmed Asangani·Nature GeneticsPeer-reviewed·Sep 9, 2024